VENCLEXTA is a BCL-2 inhibitor indicated for the treatment of patients with chronic lymphocytic leukemia (CLL) with 17p deletion, as detected by an FDA approved test, who have received at least one prior therapy. This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial. Venclexta/Venclyxto (venetoclax) was approved by Food and Drug Administration (FDA), USA: April 11, 2016, European Medical Agency (EMA), European Union, December 5, 2016, Therapeutic Goods Administration (TGA), Australia, January 5, 2017 and Health Canada, Canada, September 2016

Where can I buy Venclexta?

Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India. with over 20 years of domain experience.

The order for Venclexta (venetoclax) Tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

For Venclexta or venetoclax Tablets price in India. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
Venclexta (venetoclax)

Get In Touch

Facilitator under Patient Assistance Programs In India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Venclexta (venetoclax) on prescription and Import License in Patient's Name only.

For overseas patients, Venclexta (venetoclax) Tablets can be made available in Send your enquiry to find Venclexta (venetoclax) Tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

Dosage Forms and Strengths

Tablets: 10 mg, 50 mg, 100 mg


Immuno Oncology News

Venclexta-Rituxan Combo Delays Disease Progression in Lymphocytic Leukemia, Trial Results Show.
Dated: MARCH 26, 2018